Tectonic Therapeutic, Inc. financial data

Symbol
TECX on Nasdaq
Location
Watertown, MA
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 06 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 2226% % 313%
Debt-to-equity 5% % -93%
Return On Equity -27% % 83%
Return On Assets -26% % 40%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 18,716,280 shares 27%
Common Stock, Shares, Outstanding 18,713,223 shares 27%
Entity Public Float $115,000,000 USD 214%
Common Stock, Value, Issued $2,000 USD 0%
Weighted Average Number of Shares Outstanding, Basic 18,712,767 shares 27%
Weighted Average Number of Shares Outstanding, Diluted 18,712,767 shares 27%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense $56,303,000 USD 61%
General and Administrative Expense $20,206,000 USD 160%
Costs and Expenses $3,240,000 USD -3.3%
Operating Income (Loss) $76,509,000 USD -79%
Nonoperating Income (Expense) $10,187,000 USD 49%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $19,035,000 USD -7.4%
Income Tax Expense (Benefit) $0 USD
Net Income (Loss) Attributable to Parent $67,298,000 USD -26%
Earnings Per Share, Basic 6 USD/shares 15%
Earnings Per Share, Diluted 6 USD/shares 15%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $268,435,000 USD 69%
Other Assets, Current $626,000 USD -26%
Assets, Current $273,241,000 USD 68%
Property, Plant and Equipment, Net $1,412,000 USD -45%
Operating Lease, Right-of-Use Asset $665,000 USD -62%
Other Assets, Noncurrent $597,000 USD 214%
Assets $277,001,000 USD 64%
Accounts Payable, Current $1,485,000 USD -44%
Employee-related Liabilities, Current $3,106,000 USD 29%
Accrued Liabilities, Current $6,750,000 USD -47%
Liabilities, Current $9,373,000 USD -46%
Operating Lease, Liability, Noncurrent $0 USD -100%
Liabilities $9,473,000 USD -48%
Accumulated Other Comprehensive Income (Loss), Net of Tax $75,000 USD 2.6%
Retained Earnings (Accumulated Deficit) $203,511,000 USD -49%
Stockholders' Equity Attributable to Parent $267,528,000 USD 78%
Liabilities and Equity $277,001,000 USD 64%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $13,083,000 USD -41%
Net Cash Provided by (Used in) Financing Activities $178,122,000 USD
Net Cash Provided by (Used in) Investing Activities $27,000 USD -575%
Common Stock, Shares Authorized 150,000,000 shares 0%
Common Stock, Shares, Issued 18,713,223 shares 27%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $165,007,000 USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $269,507,000 USD 69%
Interest Paid, Excluding Capitalized Interest, Operating Activities $0 USD -100%
Deferred Tax Assets, Valuation Allowance $170,177,000 USD 463%
Deferred Tax Assets, Gross $171,270,000 USD 432%
Operating Lease, Liability $2,427,000 USD 176%
Depreciation $281,000 USD 10%
Payments to Acquire Property, Plant, and Equipment $27,000 USD 575%
Lessee, Operating Lease, Liability, to be Paid $5,400,000 USD
Property, Plant and Equipment, Gross $4,592,000 USD -12%
Operating Lease, Liability, Current $725,000 USD -51%
Lessee, Operating Lease, Liability, to be Paid, Year Two $132,000 USD
Lessee, Operating Lease, Liability, to be Paid, Year One $2,396,000 USD
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $101,000 USD
Lessee, Operating Lease, Liability, to be Paid, Year Three $0 USD
Deferred Tax Assets, Operating Loss Carryforwards $109,392,000 USD 860%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10,000,000 shares 0%
Additional Paid in Capital $471,112,000 USD 64%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization $360,000 USD -4.5%
Deferred Tax Assets, Net of Valuation Allowance $1,093,000 USD -44%
Share-based Payment Arrangement, Expense $8,625,000 USD 1988%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares